Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies

Download All
Get up to date on the evolving strategies for managing mantle cell lymphoma and diffuse large B-cell lymphoma, and watch the on-demand webcast, download slides, and read an expert-authored commentary adapted from the live symposium.
John P. Leonard, MD
Program Director
John Allan, MD
Laurie H. Sehn, MD, MPH

ClinicalThought

In this commentary, expert faculty address frequently asked questions about the selection and sequencing of therapies for patients with aggressive B-cell lymphomas.

John P. Leonard, MD
Program Director John Allan, MD Laurie H. Sehn, MD, MPH Released: January 31, 2023
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Genmab US, Inc. and AbbVie
Karyopharm Therapeutics Inc.
Regeneron Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings